Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

These data support the conduct of randomized phase III trials to evaluate the benefit of local control in patients with M1 disease at diagnosis.